01855-A: Improving Diagnosis and Treatment of Inflammatory Bowel Disease
Grant Status: Closed
AbstractInflammatory bowel disease (IBD) causes diarrhea, vomiting and weight loss, and occurs commonly in dogs worldwide. The pathogenesis of IBD is not completely understood. Although it is widely accepted that IBD may be triggered by different factors such as food sensitivity, intestinal bacterial alterations (dysbiosis) or exaggerated auto-immune response, no guidelines exist on how to differentiate between these underlying causes in a prospective manner. Current treatment recommendations are non-specific as clinical signs, standard blood testing or patterns of intestinal inflammation appear to have no relationship to the underlying cause. Treatment is therefore a case of trial and error in individual dogs. The objective of this study is to compare changes in immune mediators (cytokines) in the intestine before and after successful treatment of dogs with IBD. Dogs will be classified upon successful resolution of their diarrhea as having dietary, antibiotic or steroid responsive diarrhea. The pattern of cytokine profile will be compared between these groups. A secondary aim of the study is to determine if non-invasive methods (fecal testing of cytokines) can aid in identifying the etiology and enable monitoring of therapy success. This could lead to more targeted therapeutic options and prospective determination of treatment plans for dogs affected with IBD.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.